Figure 3
Figure 3. Low doses of RG7112 and Peg-IFNα 2a increase p53 activity. Normal (n = 5) and PV (n = 6) CD34+ cells were treated with 200 nM of RG7112 or 200 ng/mL of Peg-IFNα 2a alone or in combination. (A) Results of flow cytometric analysis of CD34+/p21+ cells in normal and PV CD34+ cells. (B) The fold change of numbers of CD34+/p21+ cells in normal and PV CD34+ cells after drug treatment. (C) Results of flow cytometric analysis of CD34+/PUMA+ cells after drug treatment of normal and PV CD34+ cells. (D) The fold change of CD34+/PUMA+ cell numbers after drug treatment of normal and PV CD34+ cells. (E) Flow cytometric analysis of CD34+/Bax+ cells after drug treatment of normal and PV CD34+ cells. (F) The fold change of numbers of CD34+/Bax+ cells after treatment of normal and PV CD34+ cells.

Low doses of RG7112 and Peg-IFNα 2a increase p53 activity. Normal (n = 5) and PV (n = 6) CD34+ cells were treated with 200 nM of RG7112 or 200 ng/mL of Peg-IFNα 2a alone or in combination. (A) Results of flow cytometric analysis of CD34+/p21+ cells in normal and PV CD34+ cells. (B) The fold change of numbers of CD34+/p21+ cells in normal and PV CD34+ cells after drug treatment. (C) Results of flow cytometric analysis of CD34+/PUMA+ cells after drug treatment of normal and PV CD34+ cells. (D) The fold change of CD34+/PUMA+ cell numbers after drug treatment of normal and PV CD34+ cells. (E) Flow cytometric analysis of CD34+/Bax+ cells after drug treatment of normal and PV CD34+ cells. (F) The fold change of numbers of CD34+/Bax+ cells after treatment of normal and PV CD34+ cells.

Close Modal

or Create an Account

Close Modal
Close Modal